Report #2838340

Received Apr 28, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: TX
Recovered: Unknown
Vaccinated: Apr 3, 2025
Onset: Apr 3, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	3334Y	—

Symptoms (1)

Blister

Symptom narrative

Blisters on nose and on back; This non-serious case was reported by a nurse via sales rep and described the occurrence of blister in a 61-year-old female patient who received Herpes zoster (Shingrix) (batch number 3334Y) for prophylaxis. On 03-APR-2025, the patient received the 1st dose of Shingrix (unknown deltoid). On 03-APR-2025, less than a day after receiving Shingrix, the patient experienced blister (Verbatim: Blisters on nose and on back). The outcome of the blister was unknown. The reporter considered the blister to be related to Shingrix. The company considered the blister to be related to Shingrix. Additional Information: GSK receipt date: 17-APR-2025 The patient experienced blisters on nose and on her back.